Insulin sensitizers in 2023: lessons learned and new avenues for investigation.
Saved in:
| Title: | Insulin sensitizers in 2023: lessons learned and new avenues for investigation. |
|---|---|
| Authors: | Colca JR; CSO, Cirius Therapeutics Inc, Kalamazoo, MI, USA., Tanis SP; SP Tanis PharmaChem Consulting, Carlsbad, CA USA., Kletzien RF; MSDC, Grand Rapids, MI, USA., Finck BN; Department of Medicine, Center for Human Nutrition, Washington University in St Louis, Euclid Ave, MO, USA. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (9), pp. 803-811. Date of Electronic Publication: 2023 Oct 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-7658 |
|---|---|
| DOI: | 10.1080/13543784.2023.2263369 |
